Farallon Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,670
| Closed | -$341K | – | 126 |
|
|
2020
Q1 | $341K | Sell |
1,670
-34,815
| -95% | -$7.11M | ﹤0.01% | 99 |
|
|
2019
Q4 | $16.3M | Sell |
36,485
-1,015
| -3% | -$454K | 0.11% | 86 |
|
|
2019
Q3 | $11.5M | Buy |
37,500
+4,167
| +13% | +$1.28M | 0.09% | 82 |
|
|
2019
Q2 | $10.6M | Buy |
+33,333
| New | +$10.6M | 0.07% | 83 |
|
|
2015
Q2 | – | Sell |
-89
| Closed | -$758K | – | 99 |
|
|
2015
Q1 | $758K | Sell |
89
-355
| -80% | -$3.02M | 0.01% | 89 |
|
|
2014
Q4 | $3.91M | Hold |
444
| – | – | 0.05% | 72 |
|
|
2014
Q3 | $2.09M | Hold |
444
| – | – | 0.03% | 73 |
|
|
2014
Q2 | $3.2M | Sell |
444
-160
| -26% | -$1.15M | 0.05% | 78 |
|
|
2014
Q1 | $3.24M | Buy |
+604
| New | +$3.24M | 0.06% | 67 |
|